Pediatrix Medical

MD

Market cap $1.77B

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, today announced the appointment of Angel S. Angelov, MD, MBA, as Chief Medical Officer (CMO), effective May 18, 2026. "We are pleased to welcome Dr. Angelov to the Vistagen team,” said President and Chief Executive Officer of Vista.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Passkey Therapeutics, the architect of the Locksmith® platform for systematically identifying new therapeutic opportunities from synergistic drug combinations, today announced the appointment of Mandeep Kaur, MD, MS, as Chief Medical Officer. Dr. Kaur will lead Passkey's clinical and medical strategy as it advances a series of Locksmith-identified drug combinations into clinical studies across multiple therapeutic areas. Dr. Kaur most recently served as Senior.

MD gains from stronger cash collections, payer mix and acquisitions, while telehealth expansion and buybacks support growth.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Pediatrix Medical Group NYSE: MD reaffirmed its full-year 2026 adjusted EBITDA outlook after reporting what management described as a strong first quarter, supported by higher pricing, improved collections and continued strength in payer mix despite modest volume declines across its service lines.

Pediatrix Medical Group tops Q1 estimates as stronger reimbursements and same-unit gains lift results despite lower patient volumes.

Pediatrix Medical Group, Inc. (MD) Q1 2026 Earnings Call Transcript

Pediatrix Medical Group (MD) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.33 per share a year ago.

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Reports First Quarter Results.